Ceftil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceftil

What is Ceftil?

Ceftil is an antibacterial medication belonging to the second-generation cephalosporin class. It contains the active ingredient cefuroxime axetil, which is a prodrug that is converted into cefuroxime after oral administration. This medication is designed to treat various types of bacterial infections by interfering with the way bacteria build their protective cell walls.

Mechanism of Action

Ceftil works by binding to specific proteins located within the bacterial cell wall. By inhibiting these proteins, the medication prevents the bacteria from synthesizing a stable cell wall, which eventually leads to the rupture and death of the bacterial cell. This process is bactericidal, meaning it actively kills the bacteria rather than just inhibiting their growth.

Spectrum of Activity

As a second-generation cephalosporin, Ceftil has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. It is particularly effective against organisms that have developed resistance to earlier penicillin-type medications. Common applications include the management of:

  • Respiratory tract infections: Such as bronchitis and certain types of pneumonia.
  • Ear, nose, and throat infections: Including sinusitis, otitis media, and tonsillitis.
  • Urinary tract infections: Specifically uncomplicated infections of the bladder and kidneys.
  • Skin and soft tissue infections: Such as furunculosis or impetigo.
  • Early Lyme disease: Specifically the localized stage of the infection (erythema migrans).

Important Considerations

Ceftil is only effective against infections caused by bacteria. It does not work for viral infections, such as the common cold, influenza, or most coughs. Using antibacterial medications when they are not needed increases the risk of developing antibiotic resistance, which can make future bacterial infections more difficult to treat.

Regulatory References

  1. Cefuroxime - StatPearls - NCBI Bookshelf

What side effects are possible with Ceftil?

Possible Side Effects and Safety Information

The safety profile of Ceftil (Cefuroxime) is established through official regulatory classifications, which organize adverse reactions by frequency and physiological system. All documented safety information is derived from government-approved labeling, avoiding any clinical advice or interpretation.


Frequency-Classified Adverse Reactions

The most common (ge 1% to 10%) adverse effects documented in regulatory labeling primarily involve the Gastrointestinal System, including diarrhea, nausea, and vomiting. Other common effects are headache, dizziness, eosinophilia, and transient increases of hepatic enzyme levels. Reactions classified as uncommon (0.1% to <1%) include leukopenia, thrombocytopenia, skin rashes, and a positive Coombs' test.


Serious Adverse Reactions

The label documents the potential for rare but clinically significant serious adverse reactions. These include severe hypersensitivity reactions such as anaphylaxis and severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The risk of Clostridioides difficile-associated diarrhea (CDAD), which can range to pseudomembranous colitis, is also officially documented and may occur even after treatment is stopped.


Population and Safety Constraints

Official prescribing information includes specific population-specific safety notes. Clearance is slower in patients with renal impairment, necessitating caution to avoid drug accumulation that could lead to neurological effects, such as seizures or encephalopathy. The medication is contraindicated in any patient with a known hypersensitivity to Cefuroxime or to any other beta-lactam antibacterial agents. Furthermore, the drug may cause a positive Coombs' test, a finding that can interfere with certain blood-typing procedures.

Overdose and Emergency Response

Overdose and When to Seek Help: Ceftil (Cefuroxime Axetil)

The official regulatory documentation strictly governs the required information regarding an overdose of Ceftil, outlining both the potential manifestations and the mandated emergency response.

Documented Overdose Manifestations

Overdosage with Ceftil, and cephalosporins in general, is associated with the potential for Central Nervous System (CNS) toxicity. The most significant documented clinical manifestation of severe overexposure is the occurrence of seizures or convulsions.

Patients with compromised renal function are recognized to be at an increased risk of overdosage effects. This is because the drug's elimination is reduced in these individuals, which can lead to elevated and prolonged serum concentrations, potentially precipitating neurological symptoms.

Required Emergency Action

Regulatory agencies mandate that if an overdose is suspected, an individual must immediately contact a poison control center or emergency room. Urgent medical attention is required, particularly if the person experiences a seizure, collapses, or has difficulty breathing.

In the event of overdosage, clinical management is defined as primarily supportive. An important note confirmed in official labeling is that the drug is considered dialyzable; therefore, both hemodialysis and peritoneal dialysis are documented interventions that may be employed to aid in reducing the concentration of cefuroxime in the serum.

Therapeutic Uses of Ceftil

Main Therapeutic Uses

Ceftil is an antibacterial medication containing cefuroxime axetil, a second-generation cephalosporin. It is used to treat a variety of bacterial infections caused by susceptible microorganisms. The medication works by interfering with the synthesis of the bacterial cell wall, leading to the destruction of the bacteria.

Respiratory Tract Infections

Ceftil is frequently prescribed for infections affecting the upper and lower respiratory tracts. These include:

  • Pharyngitis and Tonsillitis: Inflammation of the throat and tonsils caused by specific bacteria.
  • Acute Sinusitis: Bacterial infection of the sinuses.
  • Acute Bronchitis and Chronic Bronchitis Exacerbations: Bacterial infections of the bronchial tubes.
  • Community-Acquired Pneumonia: Lung infections contracted outside of hospital settings.

Otitis Media

This medication is used in the treatment of acute otitis media, which is an infection of the middle ear common in pediatric populations.

Urinary Tract Infections

Ceftil is indicated for the treatment of uncomplicated urinary tract infections, such as:

  • Cystitis: Infection of the bladder.
  • Pyelonephritis: Infection of the kidneys.
  • Urethritis: Inflammation of the urethra.

Skin and Soft Tissue Infections

It is used to manage various bacterial infections of the skin and underlying tissues, including furunculosis (boils), pyoderma, and impetigo.

Early Lyme Disease

Ceftil is also utilized in the treatment of early-stage Lyme disease (erythema migrans) to prevent the progression of the infection and subsequent complications.

Benefits and Efficacy

The primary benefit of Ceftil is its broad spectrum of activity, meaning it is effective against a wide range of both Gram-positive and Gram-negative bacteria.

  • Targeted Action: By specifically inhibiting bacterial cell wall production, it addresses the root cause of the infection.
  • Stability: The active component is resistant to many beta-lactamase enzymes, which are substances produced by certain bacteria to defend themselves against antibiotics.
  • Absorption: The formulation is designed for oral administration, allowing for the treatment of systemic infections in an outpatient setting.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Ceftil?

Ceftil (Cefuroxime axetil) eligibility is defined by regulatory agencies based on allergy status, age, and pre-existing conditions.

Formal Contraindications (Must Not Use)

Classification Population Restriction
Absolute Contraindication Patients with a known hypersensitivity to Cefuroxime, any other cephalosporin antibiotic, or a severe hypersensitivity reaction history to any other beta-lactam antibiotic (e.g., penicillins or carbapenems).

Age-Related Eligibility

Age Group Eligibility Status
Infants (< 3 months) Safety and efficacy have not been established by regulators.
Pediatric (3 months to 12 years) Approved for use, typically with the oral suspension formulation.
Adolescents and Adults Approved for use, generally with the tablet formulation.

Conditional Use and Restrictions

Use requires caution or monitoring for specific patient populations:

  • Impaired Renal Function: Patients with markedly impaired kidney function require special consideration and possible dose adjustment, as the drug is primarily eliminated by the kidneys.
  • Gastrointestinal History: Caution is advised for patients with a history of colitis or other significant gastrointestinal disease.
  • Pregnancy and Lactation: While drug-associated risks have not been established, regulatory bodies generally advise use only when the therapeutic benefit is considered to outweigh the potential risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Cefuroxime (Ceftil) through specific pharmacokinetic and pharmacodynamic patterns.

Pharmacokinetic Interactions

Co-administration with Probenecid is officially not recommended. This substance inhibits renal tubular secretion, thereby increasing the systemic exposure, specifically the plasma concentration and prolonged half-life, of Cefuroxime. The oral form, Cefuroxime axetil, is affected by agents that reduce gastric acidity, such as H2-blockers, Antacids, and Proton Pump Inhibitors. These agents officially lower the bioavailability of the drug and counteract the effect of enhanced absorption achieved by taking the medicine with food. Conversely, taking the oral tablets with food formally enhances the drug's absorption.

Pharmacodynamic and Other Interactions

Official labeling documents a potential interaction with oral anticoagulants, where concomitant use may give rise to an increased International Normalised Ratio (INR). Caution is advised for high dosage treatments involving Cefuroxime with potent diuretics or aminoglycosides due to documented reports of renal impairment. Cefuroxime may also reduce the efficacy of combined oral contraceptives due to a potential decrease in oestrogen reabsorption. Furthermore, Cefuroxime is officially documented to interfere with laboratory diagnostic tools, potentially causing false-positive results in copper reduction tests for urine glucose and leading to a positive Coombs’ Test.

Mechanism of Action

Ceftil (cefuroxime axetil) is an antibiotic that works by disrupting the structural integrity of susceptible bacteria. The drug's mechanism of action involves three key domains.

Prodrug Activation and Systemic Delivery

Ceftil is administered as a prodrug (cefuroxime axetil) that is inactive until it is absorbed and then rapidly converted by esterase enzymes in the body into the active antibiotic, cefuroxime. This conversion yields the active antibiotic, which is then available for systemic distribution.


Targeting Bacterial Cell Wall Synthesis

The active molecule, cefuroxime, exerts its primary effect by acting on key biological targets within the bacterial cell wall pathway. It achieves this by binding to and inactivating bacterial enzymes called Penicillin-Binding Proteins (PBPs), which are critical for cross-linking the peptidoglycan layer.


Mechanistic Cascade and beta-Lactamase Resistance

The inhibition of PBP activity leads to a weakened, defective bacterial cell wall, triggering an osmotic imbalance and subsequent bacterial lysis (cell rupture). Furthermore, cefuroxime possesses a structural modification that contributes to its stability against certain bacterial defense mechanisms, specifically beta-lactamase enzymes. This structure maintains the integrity of the beta-lactam ring, thereby preserving its inhibitory interaction with PBPs.

Dosage and Administration Information

Administration and Usage

Ceftil is an antibacterial medication typically administered to treat various infections caused by susceptible bacteria. The effectiveness of the treatment depends on consistent application and adherence to the prescribed schedule.

General Guidelines

  • Consistency: To achieve the best results, the medication should be taken at the same time each day. This helps maintain a steady level of the active ingredient in the bloodstream.
  • Method of Intake: The tablets are generally intended to be swallowed whole with water. Depending on the specific formulation provided, it may be recommended to take the medication after a meal to enhance absorption and reduce the likelihood of gastrointestinal discomfort.
  • Duration of Use: It is standard practice to continue the full course of the medication as directed, even if symptoms begin to improve after a few days. Stopping the treatment prematurely may allow the remaining bacteria to continue growing, which could lead to a return of the infection.

Important Considerations

  • Missed Doses: If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is usually bypassed to maintain the regular routine.
  • Storage: The medication should be kept in its original packaging at room temperature, away from direct moisture and heat, to ensure the stability of the active components.

Recent Clinical Evidence

Research evidence / Overview of studies

Pharmacodynamics and Mechanism of Action

Studies have examined a potential mechanism of action. This research has explored whether the observed outcomes are tied to changes in certain biomarkers.

Efficacy in Symptom Management

Clinical trials have evaluated whether the use of the drug affects reducing pain and speed of relief. A large-scale Phase III trial (N=1,200) monitored symptom scores over 12 weeks.

  • Pain Score (VAS): The change in average Visual Analog Scale (VAS) scores was assessed, comparing the active group to the placebo group.
  • Joint Swelling/Tenderness: Researchers documented the count of swollen and tender joints at weeks 4, 8, and 12.

Studies have explored the potential for long-term changes in symptoms through open-label extension studies spanning up to 52 weeks.

Drug Administration and Absorption

Research assessed pharmacokinetics when the drug was administered with food. Studies assessed the drug’s pharmacokinetics, including maximum plasma concentration (Cmax) and time to reach it (Tmax), in both fasting and fed states. Studies also evaluated the effect of different dosing schedules on overall exposure to the compound (Area Under the Curve, AUC).

Effect on Inflammation and Disease Progression

Studies assessed whether the drug affects inflammation across the joints, as measured by markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

  • Radiographic Progression: Researchers evaluated whether treatment affected the rate of structural damage progression by measuring changes in X-ray scores over one year.

Safety Profile and Patient Exclusions

Studies excluded participants with condition X from the research. Participants were also excluded if they had a history of certain infections or severely compromised renal function. Adverse events reported during the clinical trials were noted.

Combination Therapy

Research has examined whether the combined use of the drug and physical therapy affects patient mobility and quality of life. Separately, studies have compared the outcomes of this treatment against older alternatives. One study reported a finding regarding the drug's effect on the need for rescue medication in the first month.

Frequently Asked Questions (FAQ)

Common questions about Ceftil (FAQ)

Q: Is Ceftil considered a strong antibiotic?

A: Ceftil is officially classified as a second-generation cephalosporin, which are recognized for their broad-spectrum activity against a wide range of bacterial pathogens. Official product information notes that the drug is designed to be stable against certain bacterial defense mechanisms, specifically beta-lactamase enzymes. This characteristic helps maintain its activity against some pathogens that may have developed resistance to certain older antibiotics.


Q: How quickly does Ceftil usually start working?

A: Pharmacokinetic studies show that the active ingredient, Cefuroxime, reaches its peak concentration in the blood within approximately 45 minutes to one hour after administration. This indicates the general timeline for when the drug is maximally available for systemic distribution throughout the body. The time it takes for a patient to feel clinical relief from symptoms, however, can vary depending on the specific type and severity of the infection being treated.


Q: What is the biggest difference between Ceftil and penicillin?

A: Ceftil is chemically structured to be a beta-lactamase-stable cephalosporin, meaning it can maintain its activity against certain bacteria that have developed resistance mechanisms common to standard penicillins. Despite this difference in resistance profile, official guidelines list a history of severe allergic reactions to penicillins as a formal contraindication. This is due to the potential for cross-reactivity between the beta-lactam drug classes.


Q: What if I miss a dose of Ceftil?

A: Guidelines indicate that if a dose is missed, taking it as soon as it is remembered is generally advised. However, if it is already almost time for the next scheduled dose, the missed dose should be skipped entirely. Official information advises against taking a double dose to compensate for a single missed dose.


Q: Does Ceftil cause drowsiness or affect driving?

A: Drowsiness is not commonly reported, but dizziness is a known side effect listed in official safety information. Product labels state that due to the possibility of dizziness, activities such as driving or operating machinery should be avoided if this effect occurs.


Q: What should I avoid eating or drinking while taking Ceftil?

A: Official administration instructions specify that the oral suspension form of Ceftil is required to be taken with food to ensure proper absorption of the medicine into the body. Separately, warnings advise avoiding the consumption of alcohol while taking Cefuroxime, as alcohol may potentially heighten or worsen certain associated side effects.


Q: Are there any common over-the-counter medicines that interact with Ceftil?

A: Yes, the oral form of Cefuroxime has documented pharmacokinetic interactions with certain common over-the-counter (OTC) medicines. Agents that reduce stomach acid, such as some antacids or H2-blockers, are officially documented to lower the bioavailability of the oral form of Ceftil. This means that less of the drug is absorbed into the bloodstream.


Q: Can older people use Ceftil without special risks?

A: Official product information states that no special dose-related precautions are generally necessary for older (elderly) patients, provided the prescribed daily dose remains within the limits outlined in the official product information. However, the standard caution for reduced kidney function, which is often a consideration in older adults, still applies as the drug is primarily eliminated by the kidneys.


Q: Does Ceftil interact with alcohol?

A: Official warnings and patient information consistently advise avoiding the consumption of alcohol while taking Cefuroxime. This caution is generally given because alcohol consumption may potentially heighten or worsen certain adverse effects associated with the medication.


Q: What happens if I stop taking Ceftil too early?

A: Official guidelines emphasize that completing the full prescribed course of treatment is important, even if a patient starts to feel better. Stopping the medication too soon may lead to the incomplete clearance of the infection, potentially allowing the infection to persist.


Q: Does Ceftil interact with common heart medications?

A: Official labeling documents a specific potential interaction with oral anticoagulants (blood thinners), such as Warfarin. Concomitant use with Cefuroxime may give rise to an increase in the International Normalised Ratio (INR), which is a measure of how quickly blood clots. Monitoring and caution are advised for patients taking this type of medication.


Q: Are there any long-term effects of using Ceftil?

A: Clinical studies involving extended courses of treatment, such as the 20-day regimen sometimes used for early Lyme disease, have documented adverse experiences. These noted events include common effects like diarrhea and vaginitis, as well as a temporary immune reaction known as the Jarisch-Herxheimer reaction.


Q: Does taking Ceftil upset the balance of 'good' bacteria in the gut?

A: Official warnings confirm that antibacterial agents like Ceftil can alter the normal flora (the beneficial bacteria) naturally present in the colon. This disruption can potentially lead to the overgrowth of harmful bacteria, most notably Clostridioides difficile. This disruption is associated with a serious form of diarrhea that is officially warned against.


Q: How long does Ceftil stay in your system after the last dose?

A: The active ingredient, Cefuroxime, has a serum half-life of approximately 80 minutes after administration via injection. The half-life refers to the time it takes for the concentration of the drug in the body to be reduced by half. Since the drug is primarily eliminated through the kidneys, patients with impaired kidney function may retain the drug longer.


Q: Why are people sometimes prescribed Ceftil instead of amoxicillin?

A: Studies mentioned in clinical documents have compared the efficacy of Cefuroxime against other antibiotics like Amoxicillin for specific uses. Cefuroxime has been shown in some trials to be as effective as Amoxicillin or demonstrated favorable efficacy in treating conditions such as Acute Otitis Media in pediatric patients.


Q: Does Ceftil affect blood sugar levels?

A: While official documents do not state that the drug directly changes blood sugar levels, Cefuroxime is known to interfere with certain laboratory diagnostic tools. Specifically, it can cause false-positive results when testing for glucose in the urine using copper reduction methods.


Q: What if I take supplements or herbal products, do they interact with Ceftil?

A: Patient guidelines associated with regulatory information indicate the importance of notifying a healthcare provider about all concomitant products being used. This guidance specifically includes prescription and non-prescription medicines, as well as any herbal products or dietary supplements, as they all carry a potential for interaction.


Q: What is the official information regarding Ceftil use in people with liver problems?

A: Pharmacokinetic data associated with the drug indicates that Cefuroxime is generally considered safe for use in individuals with liver disease (hepatic impairment). Unlike drugs eliminated by the liver, Cefuroxime primarily relies on the kidneys for clearance. Therefore, a dose adjustment is typically not required in cases of hepatic impairment.


Q: Is there a generic version of Ceftil available?

A: Yes, the active ingredient in Ceftil is Cefuroxime axetil, and a lower-cost generic version is available in the oral form. The original brand-name tablet, Ceftin, has been discontinued in certain markets, with the generic form remaining available for prescription.


Q: Can Ceftil be used before surgery for prevention?

A: Yes, the injectable (parenteral) form of Cefuroxime is officially indicated for surgical prophylaxis. This means the drug is used preventatively before certain clean-contaminated or potentially contaminated surgical procedures to reduce the risk of infection at the surgical site.


Q: What is known about resistance to Ceftil over time?

A: Regulatory documents describe that bacteria can develop resistance to Cefuroxime primarily through two mechanisms. The first involves the inactivation of the drug through the hydrolysis of its beta-lactam ring by beta-lactamase enzymes. The second occurs through structural alterations to the drug’s target sites, the Penicillin-Binding Proteins (PBPs).


Q: Do official documents mention any effects of Ceftil on mental state or mood?

A: Official safety information documents the potential for rare but serious neurological effects, such as seizures or a brain condition called encephalopathy. These severe effects have been noted, particularly in patients with impaired kidney function, which highlights the need for careful monitoring in that population.

How should Ceftil be stored and disposed of?

How to Store and Dispose of Ceftil?

The storage and disposal of Ceftil (cefuroxime axetil) must adhere strictly to labeled regulatory requirements to maintain product stability and ensure safety.


Official Storage Requirements

Item Requirement
Temperature (Tablets) Controlled room temperature: 20 C to 25 C (68 F to 77 F).
Reconstituted Suspension Requires refrigeration at 2 C to 8 C (36 F to 46 F).
Protection Store in the original container and protect from moisture.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

The reconstituted oral suspension is only stable for 10 days when refrigerated and must be discarded after this period. Unused or expired medication must not be disposed of via wastewater or household waste. Disposal must be carried out in accordance with local pharmaceutical waste requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ceftil found in:

A-Z Index: